Intercon Hand Soap Recall Sparks Questions Nobody's Asking

The FDA quietly posted a recall notice last week that should have every American household pausing at the sink. Intercon Chemical Company, a Missouri-based manufacturer that supplies soap to hospitals, schools, and industrial facilities across the country, pulled multiple lots of its hand soap products after testing revealed bacterial contamination. The contaminant? Pseudomonas aeruginosa — a nasty pathogen that thrives in wet environments and can cause serious infections in people with weakened immune systems. On paper, this looks like routine regulatory housekeeping. A company finds a problem, reports it, pulls product, moves on. But the details here deserve a closer look, because the pattern keeps repeating, and nobody in the mainstream press seems interested in connecting the dots. First, consider the timing. This recall lands in the middle of a broader crisis of confidence in America's consumer safety infrastructure. We've watched lettuce recalls, baby formula shortages, and now soap — the one product literally designed to clean things — harboring bacteria. If the thing whose entire job is killing germs can't be trusted, what exactly is the FDA doing with its $6.5 billion budget? Second, consider the supply chain. Intercon isn't a boutique brand you'd find at Whole Foods. Its products flow into institutional settings — the exact places where vulnerable populations live and receive care. Nursing homes. Hospitals. Daycares. These are the facilities where a Pseudomonas infection isn't just inconvenient; it can be lethal. The recall notice doesn't specify which facilities received the contaminated lots, which means millions of Americans have no way of knowing whether their workplace, their child's school, or their grandmother's assisted living center was affected. Third — and this is where it gets interesting — this isn't Intercon's first rodeo. The company has faced regulatory scrutiny before, and the broader chemical manufacturing sector has a long history of cutting corners on quality control while lobbying against stricter oversight. The revolving door between regulatory agencies and the industries they're supposed to police is not a conspiracy theory; it's a documented, well-funded reality. Former FDA officials regularly cycle into consulting roles for the very companies they once inspected. So why isn't this story everywhere? Because it doesn't fit a neat partisan narrative. It's not a red team or blue team issue. It's a structural issue — one that both parties have spent decades ignoring while campaign donations flowed in from the chemical and pharmaceutical sectors. What can you actually do? Check the FDA's recall database directly rather than waiting for it to trend on social media. If you work in healthcare or education, ask your facility manager whether Intercon products were in rotation. And pay attention to the pattern, not just the individual recall. One contaminated batch is an accident. A system that keeps producing these accidents — and keeps burying the story — is something else entirely. The soap opera at your sink might be more literal than you think. Stay skeptical, read the fine print, and remember that "FDA-approved" has never meant "FDA-guaranteed." **Closing opinion:** The real scandal isn't that one company's soap got contaminated — it's that we've built an entire regulatory culture where that's treated as business as usual. Until Americans start demanding transparency as loudly as they demand convenience, these recalls will keep coming, and the dots will keep going unconnected.